These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization. Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724 [TBL] [Abstract][Full Text] [Related]
25. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences. Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859 [TBL] [Abstract][Full Text] [Related]
26. Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis. Baumgartner M; Lang M; Holley H; Crepaz D; Hausmann B; Pjevac P; Moser D; Haller F; Hof F; Beer A; Orgler E; Frick A; Khare V; Evstatiev R; Strohmaier S; Primas C; Dolak W; Köcher T; Klavins K; Rath T; Neurath MF; Berry D; Makristathis A; Muttenthaler M; Gasche C Gastroenterology; 2021 Oct; 161(4):1245-1256.e20. PubMed ID: 34146566 [TBL] [Abstract][Full Text] [Related]
27. Healthy human gut phageome. Manrique P; Bolduc B; Walk ST; van der Oost J; de Vos WM; Young MJ Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10400-5. PubMed ID: 27573828 [TBL] [Abstract][Full Text] [Related]
28. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Lee M; Chang EB Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681 [TBL] [Abstract][Full Text] [Related]
30. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Jackson DN; Theiss AL Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966 [TBL] [Abstract][Full Text] [Related]
31. Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses. Kunath BJ; Hickl O; Queirós P; Martin-Gallausiaux C; Lebrun LA; Halder R; Laczny CC; Schmidt TSB; Hayward MR; Becher D; Heintz-Buschart A; de Beaufort C; Bork P; May P; Wilmes P Microbiome; 2022 Dec; 10(1):243. PubMed ID: 36578059 [TBL] [Abstract][Full Text] [Related]
33. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Liu Z; Cao AT; Cong Y Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482 [TBL] [Abstract][Full Text] [Related]
34. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. Shah A; Macdonald GA; Morrison M; Holtmann G Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997 [TBL] [Abstract][Full Text] [Related]
35. Novel Inter-omic Analysis Reveals Relationships Between Diverse Gut Microbiota and Host Immune Dysregulation in HLA-B27-Induced Experimental Spondyloarthritis. Gill T; Brooks SR; Rosenbaum JT; Asquith M; Colbert RA Arthritis Rheumatol; 2019 Nov; 71(11):1849-1857. PubMed ID: 31216122 [TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor signaling in intestinal permeability regulation. Pontarollo G; Mann A; Brandão I; Malinarich F; Schöpf M; Reinhardt C FEBS J; 2020 Feb; 287(4):645-658. PubMed ID: 31495063 [TBL] [Abstract][Full Text] [Related]
37. Sialylation in the gut: From mucosal protection to disease pathogenesis. Ma X; Li M; Wang X; Qi G; Wei L; Zhang D Carbohydr Polym; 2024 Nov; 343():122471. PubMed ID: 39174097 [TBL] [Abstract][Full Text] [Related]
38. Gut microbiome in primary sclerosing cholangitis: A review. Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753 [TBL] [Abstract][Full Text] [Related]
39. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026 [TBL] [Abstract][Full Text] [Related]
40. Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice. Li S; Zhuge A; Wang K; Lv L; Bian X; Yang L; Xia J; Jiang X; Wu W; Wang S; Wang Q; Li L Food Funct; 2021 Oct; 12(20):10210-10225. PubMed ID: 34542110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]